Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update
May 02, 2018 11:31 am UTC| Business
SAN DIEGO, May 02, 2018 -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will report financial results for the first...
MGP Ingredients Reports First Quarter 2018 Results
May 02, 2018 11:31 am UTC| Business
ATCHISON, Kan., May 02, 2018 -- MGP Ingredients, Inc. (Nasdaq/MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today reported results for the first quarter ended March...
Oz Management Reports First Quarter of 2018 Results
May 02, 2018 11:31 am UTC| Business
NEW YORK, May 02, 2018 -- Och-Ziff Capital Management Group LLC (NYSE:OZM) (the “Company” or “Oz Management”) announced its results for the first quarter of 2018 and a dividend today. To view the detailed earnings...
Insmed Reports First Quarter 2018 Financial Results and Provides Business Update
May 02, 2018 11:31 am UTC| Business
Submitted NDA to FDA for Amikacin Liposome Inhalation Suspension (ALIS) in NTM lung disease caused by MAC; anticipates priority reviewActively preparing for potential product launch of ALIS in 4Q 2018 BRIDGEWATER,...
The Madison Square Garden Company Reports Fiscal 2018 Third Quarter Results
May 02, 2018 11:30 am UTC| Business
Fiscal 2018 third quarter revenue of $459.6 million, up 19% versus prior year periodFiscal 2018 third quarter operating income of $7.3 million, up 9% versus prior year periodFiscal 2018 third quarter adjusted operating...
Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
May 02, 2018 11:30 am UTC| Business
RADNOR, Pa., May 02, 2018 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
May 02, 2018 11:30 am UTC| Business
DALLAS and FORT WORTH, Texas, May 02, 2018 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...